SRX Global Inc. has amended its previously disclosed stock repurchase program to authorize the purchase of up to $20 million in common stock. The amendment was executed via a Limited Consent and Amendment Agreement dated September 8, 2026.
Under the terms of the new plan, the company may repurchase shares of its common stock, par value $0.001 per share, for an aggregate purchase price not to exceed $20 million. The repurchases are permitted through July 7, 2027.
The company is permitted to buy shares up to the lesser of two metrics: 10,000,000 shares or 50% of the issued and outstanding common stock at any specific time.
This authorization follows a Securities Purchase Agreement entered into on August 27, 2026, in which the company sold 3,579 shares of Series C convertible preferred stock to accredited investors for an aggregate purchase price of $2.825 million.
